VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice

Dextran sulphate sodium colitis in C57BL/6J mice is alleviated by Lactococcus lactis and worsened by the neutralization of Tumor necrosis Factor α

(2017) Aleš Berlec et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Probiotics and prebiotics in ulcerative colitis

(2016) Lauranne A.A.P. Derikx et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Mucosa-reparing and microbiota-balancing therapeutic effect of Bacillus subtilis alleviates dextrate sulfate sodium-induced ulcerative colitis in mice

(2016) Hui-Lu Zhang et al.   Experimental and Therapeutic Medicine

Inhibition of Chronic Ulcerative Colitis-associated Adenocarcinoma Development in Mice by VSL#3

(2015) Elena Talero et al.   INFLAMMATORY BOWEL DISEASES

Role of the intestinal microbiota and fecal transplantation in inflammatory bowel diseases

(2014) Jie Liang et al.   Journal of Digestive Diseases

5-Aminosalicylates Reduce the Risk of Colorectal Neoplasia in Patients with Ulcerative Colitis: An Updated Meta-Analysis

(2014) Li-Na Zhao et al.   PLoS One

Effect of Probiotics on Inducing Remission and Maintaining Therapy in Ulcerative Colitis, Crohnʼs Disease, and Pouchitis

(2013) Jun Shen et al.   INFLAMMATORY BOWEL DISEASES

The possible effects of mesalazine on the intestinal microbiota

(2012) L. Xue et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort Studies

(2012) Tine Jess et al.   Clinical Gastroenterology and Hepatology

Immunoregulatory Mechanisms Underlying Prevention of Colitis-Associated Colorectal Cancer by Probiotic Bacteria

(2012) Josep Bassaganya-Riera et al.   PLoS One

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment

(2012) Xochitl C Morgan et al.   GENOME BIOLOGY

Ulcerative Colitis-Associated Colorectal Cancer Arises in a Field of Short Telomeres, Senescence, and Inflammation

(2011) R. A. Risques et al.   CANCER RESEARCH

Lactobacillus bulgaricus OLL1181 activates the aryl hydrocarbon receptor pathway and inhibits colitis

(2011) Takeyuki Takamura et al.   IMMUNOLOGY AND CELL BIOLOGY

Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study

(2010) Antonio Tursi et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Effect of dietary inorganic sulfur level on growth performance, fecal composition, and measures of inflammation and sulfate-reducing bacteria in the intestine of growing pigs1

(2010) B. J. Kerr et al.   JOURNAL OF ANIMAL SCIENCE

Use of probiotics in gastrointestinal disorders: what to recommend?

(2010) Elizabeth C. Verna et al.   Therapeutic Advances in Gastroenterology

Inflammation and Cancer: IL-6 and STAT3 Complete the Link

(2009) Jacqueline Bromberg et al.   CANCER CELL

The Probiotic Preparation, VSL#3 Induces Remission in Patients With Mild-to-Moderately Active Ulcerative Colitis

(2009) Ajit Sood et al.   Clinical Gastroenterology and Hepatology

Effects of mesalamine (5-aminosalicylic acid) on bacterial gene expression

(2009) Jaime Kaufman et al.   INFLAMMATORY BOWEL DISEASES

Modulation of the Intestinal Microbiota Alters Colitis-Associated Colorectal Cancer Susceptibility

(2009) Joshua M. Uronis et al.   PLoS One

Role of toll-like receptors in tissue repair and tumorigenesis

(2008) S. Rakoff-Nahoum et al.   BIOCHEMISTRY-MOSCOW